Graham Number Checker

Date Checked2025-12-21 23:44:12
Graham Number(PB)62.42 vs (PE)64.24
Over / Under Value Percentage188.44% vs 185.52%
Dividend Yield0.00%
Dividend DateNone
SymbolALXN
AssetTypeCommon Stock
NameAlexion Pharmaceuticals, Inc
DescriptionAlexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases.
CIK899866
ExchangeNASDAQ
CurrencyUSD
CountryUSA
SectorLIFE SCIENCES
IndustryPHARMACEUTICAL PREPARATIONS
Address121 SEAPORT BOULEVARD, BOSTON, MA, US
FiscalYearEndDecember
LatestQuarter2021-03-31
MarketCapitalization40534884000
EBITDA3263300000
PERatio59.53
PEGRatio1.195
BookValue56.21
DividendPerShareNone
EPS3.081
RevenuePerShareTTM28.5
ProfitMargin0.109
OperatingMarginTTM0.474
ReturnOnAssetsTTM0.101
ReturnOnEquityTTM0.0443
RevenueTTM6261600000
GrossProfitTTM5516400000
DilutedEPSTTM3.081
QuarterlyEarningsGrowthYOY0.144
QuarterlyRevenueGrowthYOY0.133
AnalystTargetPrice177.36
TrailingPE59.53
ForwardPE14.12
PriceToSalesRatioTTM6.6
PriceToBookRatio3.316
EVToRevenue6.45
EVToEBITDA43.46
Beta1.281
52WeekHigh186.52
52WeekLow99.91
50DayMovingAverage180.05
200DayMovingAverage163.43
SharesOutstanding221019000
SharesFloat220109000
SharesShort8553600
SharesShortPriorMonth8455900
ShortRatio4.62
ShortPercentOutstanding0.04
ShortPercentFloat0.0389
PercentInsiders0.339
PercentInstitutions88.18
ForwardAnnualDividendRate0
ForwardAnnualDividendYield0
PayoutRatio0
ExDividendDateNone
LastSplitFactor2:1
LastSplitDate2011-05-23
dateChecked2025-12-21 23:44:12